← Back to Clinical Trials
Recruiting NCT06367348

NCT06367348 An Economic and Relationship-strengthening Intervention to Reduce Alcohol Use in Malawi

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06367348
Status Recruiting
Phase
Sponsor University of California, San Francisco
Condition HIV/AIDS
Study Type INTERVENTIONAL
Enrollment 500 participants
Start Date 2025-02-14
Primary Completion 2028-05

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Mlambe

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 500 participants in total. It began in 2025-02-14 with a primary completion date of 2028-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

With a full-scale randomized control trial, the investigators will evaluate the efficacy and cost effectiveness of Mlambe, an economic and relationship-strengthening intervention that provides incentivized saving accounts, financial literacy training, and relationship skills education to break the cycle of poverty around drinking, strengthen couple support and communication, and reduce heavy drinking among HIV-affected married couples with a partner who drinks alcohol in Malawi.

Eligibility Criteria

Inclusion Criteria: 1. In a married or cohabitating union 2. Have at least one partner with a positive AUDIT-C screen in prior 3 months 3. Must also currently be on ART for at least 6 months 4. Must have disclosed their HIV status to their partner Exclusion Criteria: 1\) Severe intimate partner violence reported in previous 3 months and/or fear that safety would be at risk by participation in the study (reported at screening). Couples who participated in Mlambe's pilot study will also be excluded.

Contact & Investigator

Central Contact

James Mkandawire

✉ james3mkandawire@gmail.com

📞 +265 8883 70081

Principal Investigator

Amy Conroy, PhD

PRINCIPAL INVESTIGATOR

University of California, San Francisco

Frequently Asked Questions

Who can join the NCT06367348 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying HIV/AIDS. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06367348 currently recruiting?

Yes, NCT06367348 is actively recruiting participants. Contact the research team at james3mkandawire@gmail.com for enrollment information.

Where is the NCT06367348 trial being conducted?

This trial is being conducted at Zomba, Malawi.

Who is sponsoring the NCT06367348 clinical trial?

NCT06367348 is sponsored by University of California, San Francisco. The principal investigator is Amy Conroy, PhD at University of California, San Francisco. The trial plans to enroll 500 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology